ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Infectious Disease

Top Infectious Disease Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
SERENA LEE M.D.

Infectious Disease

19,151

$1.42M

737
547 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 49%

$74
Average prescription price

Avg: $288

ALEXIS CORAZON MD

Infectious Disease

16,317

$2.3M

236
117 are 65+

64%
patients receiving schedule two controlled substances

Avg: 8%

12%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

43%
prescriptions for brand name drugs

Avg: 49%

$141
Average prescription price

Avg: $288

MOHAMMAD IBRAHIM MD

Infectious Disease

16,047

$1.73M

364
202 are 65+

17%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

46%
prescriptions for brand name drugs

Avg: 49%

$108
Average prescription price

Avg: $288

NADER MOAVEN MD

Infectious Disease

11,926

$1.47M

674
492 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

2%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 49%

$124
Average prescription price

Avg: $288

RODOLFO MUNERA MD

Infectious Disease

10,451

$1.14M

333
250 are 65+

9%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 49%

$109
Average prescription price

Avg: $288

JIHAD SLIM MD

Infectious Disease

10,221

$5.03M

386
89 are 65+

20%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

64%
prescriptions for brand name drugs

Avg: 49%

$492
Average prescription price

Avg: $288

DAVID CONDOLUCI D.O.

Infectious Disease

7,906

$3.43M

221
58 are 65+

23%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

52%
prescriptions for brand name drugs

Avg: 49%

$434
Average prescription price

Avg: $288

JUDITH LIGHTFOOT D.O.

Infectious Disease

5,592

$2.53M

302
82 are 65+

19%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 49%

$453
Average prescription price

Avg: $288

JEAN MESSIHI M.D.

Infectious Disease

5,445

$623K

267
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

40%
prescriptions for brand name drugs

Avg: 49%

$115
Average prescription price

Avg: $288

ALEXANDER STOLER M.D.

Infectious Disease

5,251

$2.65M

164
20 are 65+

30%
patients receiving schedule two controlled substances

Avg: 8%

9%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

63%
prescriptions for brand name drugs

Avg: 49%

$504
Average prescription price

Avg: $288

RAJASINGAM JAYASINGAM M.D.

Infectious Disease

4,224

$1.27M

235
81 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

47%
prescriptions for brand name drugs

Avg: 49%

$300
Average prescription price

Avg: $288

MOHAMED RABBAT M.D.

Infectious Disease

4,151

$1.52M

117
38 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

51%
prescriptions for brand name drugs

Avg: 49%

$367
Average prescription price

Avg: $288

ANA RODRIGUEZ M.D.

Infectious Disease

4,026

$965K

137
77 are 65+

12%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

45%
prescriptions for brand name drugs

Avg: 49%

$240
Average prescription price

Avg: $288

PRADIP SHAH MD

Infectious Disease

3,889

$574K

175
127 are 65+

10%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 49%

$148
Average prescription price

Avg: $288

DEBRA CHEW M.D.

Infectious Disease

3,797

$1.48M

102
15 are 65+

34%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 49%

$389
Average prescription price

Avg: $288

DOUGLAS TAYLOR M.D.

Infectious Disease

3,479

$1.96M

128
38 are 65+

11%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

72%
prescriptions for brand name drugs

Avg: 49%

$563
Average prescription price

Avg: $288

SPARTACO BELLOMO M.D.P.A.

Infectious Disease

3,391

$1.25M

115
79 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

10%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

53%
prescriptions for brand name drugs

Avg: 49%

$368
Average prescription price

Avg: $288

KATHLEEN CASEY MD

Infectious Disease

3,254

$1.75M

164
38 are 65+

15%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

62%
prescriptions for brand name drugs

Avg: 49%

$537
Average prescription price

Avg: $288

LAWRENCE NASTRO MD

Infectious Disease

3,127

$334K

306
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 49%

$107
Average prescription price

Avg: $288

SESSINE NAJJAR M.D.

Infectious Disease

3,123

$393K

228
198 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

38%
prescriptions for brand name drugs

Avg: 49%

$126
Average prescription price

Avg: $288

GABRIELLA WEISS MD

Infectious Disease

3,043

$238K

196
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 49%

$78
Average prescription price

Avg: $288

DIANA FINKEL DO

Infectious Disease

2,814

$707K

218
165 are 65+

6%
patients receiving schedule two controlled substances

Avg: 8%

8%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 49%

$251
Average prescription price

Avg: $288

LEWIS MARTON M.D.

Infectious Disease

2,504

$1.12M

88
11 are 65+

22%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

56%
prescriptions for brand name drugs

Avg: 49%

$447
Average prescription price

Avg: $288

JACK BOGHOSSIAN M.D.

Infectious Disease

2,428

$1.19M

103
25 are 65+

27%
patients receiving schedule two controlled substances

Avg: 8%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

66%
prescriptions for brand name drugs

Avg: 49%

$492
Average prescription price

Avg: $288

ATHANASIOS PAPASTAMELOS DO

Infectious Disease

2,359

$780K

398
291 are 65+

5%
patients receiving schedule two controlled substances

Avg: 8%

3%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

41%
prescriptions for brand name drugs

Avg: 49%

$330
Average prescription price

Avg: $288

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank